FNY Investment Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-7,624
Closed -$58K 1456
2025
Q3
$58K Sell
7,624
-7,099
-48% -$55.4K 0.02% 474
2025
Q2
$128K Buy
+14,723
New +$107K 0.05% 268
2024
Q4
Sell
-296
Closed -$2K 927
2024
Q3
$2K Sell
296
-18,592
-98% -$154K ﹤0.01% 611
2024
Q2
$184K Buy
18,888
+18,838
+37,676% +$230K 0.12% 125
2024
Q1
$0 Hold
50
﹤0.01% 844
2023
Q4
$1K Hold
50
﹤0.01% 448
2023
Q3
$0 Hold
50
﹤0.01% 751
2023
Q2
$1K Hold
50
﹤0.01% 500
2023
Q1
$1K Hold
50
﹤0.01% 525
2022
Q4
$1K Sell
50
-100
-67% -$2.7K ﹤0.01% 466
2022
Q3
$3K Buy
150
+50
+50% +$1.75K ﹤0.01% 520
2022
Q2
$3K Buy
100
+75
+300% +$3.19K ﹤0.01% 556
2022
Q1
$1K Sell
25
-16,475
-100% -$1.19M ﹤0.01% 692
2021
Q4
$1.51M Buy
16,500
+16,400
+16,400% +$1.96M 0.81% 28
2021
Q3
$12K Buy
+100
New +$14.6K 0.01% 530
2021
Q2
Sell
-25
Closed -$4K 963
2021
Q1
$4K Buy
+25
New +$5.8K ﹤0.01% 660

Other funds holding TDOC

FNY Investment Advisers's TDOC Position: Q4 2025 in Review

FNY Investment Advisers sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 7,624 shares — an estimated $58K sold.

FNY Investment Advisers first reported a position in TDOC in Q1 2021 and held it in 16 quarters. The position peaked at $1.51M in Q4 2021. 345 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • FNY Investment Advisers reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 7,624 Teladoc Health shares in Q4 2025, an estimated $58K.
  • FNY Investment Advisers first reported a position in Teladoc Health in Q1 2021 and held it in 16 quarters.
  • FNY Investment Advisers's Teladoc Health position peaked at $1.51M in Q4 2021.
  • 345 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.